ReleaseWire Connect

Women’s have several health issues such as breast cancer, osteoporosis, sexually transmitted infections and cervical cancer. In women’s the chances of infertility, cancer and osteoporosis increases with age. Globally, breast cancer is the leading cause of death in women’s. Approximately one in every eight women in the U.S. develops breast cancer in their lifetime. Early diagnoses of these diseases can help in effective treatment. Bone density tests, mammography, breast biopsy and ultrasound are some of the imaging techniques for the diagnosis of women’s health issues.

Refrigerated vehicles are used for transportation of vulnerable food, pharmaceutical and healthcare products. The increasing population and consumer spending on food products has surged their production globally. Among food products, dairy products and fresh fruits and vegetables require cold storage and transportation for their sustainability. The increasing global warming has been emerging as a matter of great concern for the food producers globally which is reducing the shelf life of these products in non-refrigerated conditions. Most of the pharmaceutical and healthcare products need protection from heat and light to maintain their chemical and biological formulation. All these concerns have been driving the refrigerated vehicles market globally and are expected to increase in terms of growth rate during 2014-2020.

Diabetic nephropathy is a disease of kidney glomerulus. Diabetic nephropathy is caused by high blood sugar or diabetes and high blood pressure and results in kidney damage. Balanced glomerular filtration rate decreases in the damage to kidney. Decrease in the filtration rates builds up waste products in the blood and increases the level of protein in urine. Severe kidney damage can lead to kidney failure which required kidney transplantation. Treatment of diabetic nephropathy includes glycemic control and blood pressure control. Rise in incidence of diabetes cases and increasing awareness about the diabetes and its treatment therapies are some of the major factors which are driving the market for diabetic nephropathy. Some of the symptoms of diabetic nephropathy are abnormal sensations to body part, loss of control over bladder, intense pain, erectile dysfunction, dizziness, speech impairment and others. Diabetic nephropathy therapies include drugs therapy, physiotherapy and radio therapy. Drugs therapy includes antispasmodic and antidepressant. Radio therapy includes transcutaneous electric nerve stimulation (TENS). These therapies help to control diabetes diabetic nephropathy that can cause eye damage and heart disease.

PC (Perspective Control) lenses allow the photographers to adjust and control the appearance of the viewpoint in the image. Very often they are used to prevent the meeting of parallel lines especially at the time of photographing a tall object. Lenses which offer only shift are called shift lenses while some lenses can also tilt and are called tilt shift lenses. Short-focus PC lenses are used mainly in architectural photography and other applications such as landscape, product and closeup photography. PC lenses are generally hold the application in single-lens reflex (SLR) cameras as photographer is not able to view directly the effect of lens by range finder camera. A PC Lenses have a bigger image circle than needed to capture the image area.

Companion diagnostics refer to the test or measurement which provides essential information about the patient’s genetic and genomic characteristics to the physicians for making treatment decision. This information is important for the safe and effective use of corresponding drugs and therapies in the treatment. Rise in awareness about personalized medicines, technological advancement and government initiatives are some of the major factors which are driving the companion diagnostics market. Companion diagnostics helps to improve clinical outcome and cost saving. Companion diagnostics are used in drug discovery and development in a cost effective manner. In addition, companion diagnostics also used to manage side effects from the drug and therapies. On the basis of technology, companion diagnostics market can be segmented into polymerase chain reaction (PCR), in-situ hybridization (ISH), immunohistochemistry (IHC) and others. On the basis of application, companion diagnostics market can be segmented into breast cancer, gastric cancer, lung cancer, colorectal cancer, melanoma and others. On the basis of end user, companion diagnostics market can be segmented into pharmaceutical companies, reference lab and others. Companion diagnostics methodology includes genetic tests platforms, enzyme-linked immunosorbent assays, immunohistochemistry, proteomic assays and others. Companion diagnostics reduce costs related to hospitalization due to unnecessary treatment.

Iodine is a non-metallic element with symbol I and atomic number 53. It is one of the elements in group of elements, called halogen in the periodic table. Iodine is one of the rare elements found in seawater, seaweed, and in some minerals. It is one of the essential trace elements needed in regular diet for human nutrition, but iodine is toxic in its elemental form. Some of the properties of iodine are dark gray color, lustrous solid with a faintly bluish tinge and after heat, much of the substance turns directly into a vapor.

According to a new market report published by Persistence Market Research “Global Market Study on Medical Fiber Optics: Asia to Witness Highest Growth by 2019,” the global medical fiber optics market was valued at USD 863.1 million in 2013 and is expected to grow at a CAGR of 7.6% from 2013 to 2019, to reach an estimated value of USD 1,336.1 million in 2019.

Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020” the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.

According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

According to a new market report published by Persistence Market Research “Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020,” the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020.